DK1180155T3 - Vektor til integration af heterologe sekvenser i poxvirale genomer - Google Patents

Vektor til integration af heterologe sekvenser i poxvirale genomer

Info

Publication number
DK1180155T3
DK1180155T3 DK00938684T DK00938684T DK1180155T3 DK 1180155 T3 DK1180155 T3 DK 1180155T3 DK 00938684 T DK00938684 T DK 00938684T DK 00938684 T DK00938684 T DK 00938684T DK 1180155 T3 DK1180155 T3 DK 1180155T3
Authority
DK
Denmark
Prior art keywords
vector
integration
heterologous sequences
poxviral
genomes
Prior art date
Application number
DK00938684T
Other languages
English (en)
Inventor
Marion Ohlmann
Volker Erfle
Stefan Wintersperger
Robert Baier
Gerd Sutter
Original Assignee
Helmholtz Zentrum Muenchen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Helmholtz Zentrum Muenchen filed Critical Helmholtz Zentrum Muenchen
Application granted granted Critical
Publication of DK1180155T3 publication Critical patent/DK1180155T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK00938684T 1999-05-28 2000-05-25 Vektor til integration af heterologe sekvenser i poxvirale genomer DK1180155T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA199900753 1999-05-28
PCT/EP2000/004786 WO2000073476A1 (en) 1999-05-28 2000-05-25 Vector for integration of heterologous sequences into poxviral genomes

Publications (1)

Publication Number Publication Date
DK1180155T3 true DK1180155T3 (da) 2009-02-16

Family

ID=8097154

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00938684T DK1180155T3 (da) 1999-05-28 2000-05-25 Vektor til integration af heterologe sekvenser i poxvirale genomer

Country Status (9)

Country Link
US (2) US6682742B1 (da)
EP (1) EP1180155B1 (da)
JP (2) JP5639736B2 (da)
AT (1) ATE412762T1 (da)
AU (1) AU5397100A (da)
CA (1) CA2372709C (da)
DE (1) DE60040662D1 (da)
DK (1) DK1180155T3 (da)
WO (1) WO2000073476A1 (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP927599A0 (en) * 1999-03-17 1999-04-15 Curtin University Of Technology Tinnitus rehabilitation device and method
DK1180155T3 (da) * 1999-05-28 2009-02-16 Helmholtz Zentrum Muenchen Vektor til integration af heterologe sekvenser i poxvirale genomer
DE10143490C2 (de) * 2001-09-05 2003-12-11 Gsf Forschungszentrum Umwelt Rekombinantes MVA mit der Fähigkeit zur Expression von HCV Struktur-Antigenen
CN101831411A (zh) 2002-05-16 2010-09-15 巴法里安诺迪克有限公司 表达插入痘病毒基因组中的同源基因的重组痘病毒
US7501127B2 (en) * 2002-05-16 2009-03-10 Bavarian Nordic A/S Intergenic regions as novel sites for insertion of HIV DNA sequences in the genome of Modified Vaccinia virus Ankara
JP2005525821A (ja) * 2002-05-16 2005-09-02 バヴァリアン・ノルディック・アクティーゼルスカブ 牛痘ａｔｉプロモーターを用いた変異ワクシニアウイルスアンカラ中の遺伝子の発現
AU2007200016B2 (en) * 2002-05-16 2010-04-22 Bavarian Nordic A/S Intergenic regions as novel sites for insertion of HIV DNA sequences in the genome of modified vaccinia virus ankara
US7300658B2 (en) * 2002-11-25 2007-11-27 Bavarian Nordic A/S Recombinant poxvirus comprising at least two compox ATI promoters
US7638134B2 (en) * 2003-02-20 2009-12-29 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Insertion sites in fowlpox vectors
EP1518932A1 (en) * 2003-09-29 2005-03-30 GSF-Forschungszentrum für Umwelt und Gesundheit GmbH Modified vaccinia virus Ankara (MVA) mutant and use thereof
US7972605B2 (en) * 2006-09-08 2011-07-05 Duke University Modified vaccinia ankara virus vaccine
GB201006405D0 (en) 2010-04-16 2010-06-02 Isis Innovation Poxvirus expression system

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5364773A (en) * 1991-03-07 1994-11-15 Virogenetics Corporation Genetically engineered vaccine strain
CA1322731C (en) 1986-09-22 1993-10-05 Hisatoshi Shida Gene for a-type inclusion body of poxvirus
JPH0795956B2 (ja) * 1986-09-22 1995-10-18 京都大学長 ポックスウイルス由来発現制御領域
US5443964A (en) * 1987-08-10 1995-08-22 Duke University Poxvirus insertion/expression vector
CA1341245C (en) * 1988-01-12 2001-06-05 F. Hoffmann-La Roche Ag Recombinant vaccinia virus mva
JP2679711B2 (ja) * 1988-02-09 1997-11-19 京都大学長 ボックスウイルスのａ型封入体（ａｔｉ）遺伝子５′上流領域の改良及び当該遺伝子３′下流領域による外来遺伝子発現ベクターの改良
US5997878A (en) * 1991-03-07 1999-12-07 Connaught Laboratories Recombinant poxvirus-cytomegalovirus, compositions and uses
DE4405841C1 (de) * 1994-02-23 1995-01-05 Mayr Anton Prof Dr Med Vet Dr Multipotente Paramunitätsinducer auf der Basis von Kombinationen von Pockenviruskomponenten, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
UA68327C2 (en) * 1995-07-04 2004-08-16 Gsf Forschungszentrum Fur Unwe A recombinant mva virus, an isolated eukaryotic cell, infected with recombinant mva virus, a method for production in vitro of polypeptides with use of said cell, a method for production in vitro of virus parts (variants), vaccine containing the recombinant mva virus, a method for immunization of animals
AU4556597A (en) * 1996-09-24 1998-04-17 Bavarian Nordic Research Institute A/S Recombinant mva virus expressing dengue virus antigens, and the use thereof in vaccines
GB9711957D0 (en) 1997-06-09 1997-08-06 Isis Innovation Methods and reagents for vaccination
DK1180155T3 (da) * 1999-05-28 2009-02-16 Helmholtz Zentrum Muenchen Vektor til integration af heterologe sekvenser i poxvirale genomer

Also Published As

Publication number Publication date
US7150874B2 (en) 2006-12-19
EP1180155A1 (en) 2002-02-20
CA2372709C (en) 2011-10-25
JP2011234731A (ja) 2011-11-24
ATE412762T1 (de) 2008-11-15
DE60040662D1 (de) 2008-12-11
AU5397100A (en) 2000-12-18
JP2003501039A (ja) 2003-01-14
EP1180155B1 (en) 2008-10-29
US6682742B1 (en) 2004-01-27
JP5639736B2 (ja) 2014-12-10
WO2000073476A1 (en) 2000-12-07
US20040228840A1 (en) 2004-11-18
CA2372709A1 (en) 2000-12-07

Similar Documents

Publication Publication Date Title
DK1180155T3 (da) Vektor til integration af heterologe sekvenser i poxvirale genomer
WO2005049844A3 (en) Vectors, mutant viruses and methods for generating mutant viruses
DK0937098T3 (da) Rekombinatorisk kloning under anvendelse af gensplejsede rekombinationssites
DK0695361T4 (da) Ekspression af heterologe gener ifølge en målekspressionsprofil
DE60143564D1 (de) Veränderte rekombinasen zur modifizierung des genoms
HK1076835A1 (en) Expression of genes in modified vaccinia virus ankara by using the cowpox ati promoter
DK1234024T4 (da) Kunstige chromosomkonstruktioner, der indeholder nucleinsyresekvenser, som er i stand til at dirigere dannelsen af et rekombinant RNA-virus
DK1176205T3 (da) Ekspression af alkalisk phosphatase i gær
IL145797A0 (en) Production of attenuated negative stranded rna virus vaccines from cloned nucleotide sequences
EP1721981A4 (en) RECOMBINANT VARICELLA ZOSTER VIRUS
WO2002081709A3 (en) Modified hpv e6 and e7 genes and proteins useful for vaccination
DK1356062T3 (da) Frembringelse af rekombinanter af kunstigt gærkromosom af human cytomegalovirus
AU5460900A (en) Infectious cdna clone of gb virus b and uses thereof
BR9806084A (pt) Vetor de poliovirus sabin tipo i, recombinante ou quimérico de replicação competente, seus métodos de produção e célula hospedeira
WO2002059330A8 (en) Artificial chromosomes comprising concatemers of expressible nucleotide sequences
WO2002079409A3 (en) Integrases for the insertion of heterologous nucleic acids into the plastid genome
ES2125842A1 (es) Clones y vectores infectivos de plantas derivados del virus del mosaico del nabo (tumv).
WO2002081632A3 (en) Nucleic acids for transgene expression
ATE301710T1 (de) Nukleinsäure-isolierung
WO2001011065A3 (en) Hepatitis a virus clones adapted for growth in agmk cells
WO2001004315A3 (en) Ringene compositions and methods for use thereof
WO2001075127A3 (de) Klonierungssystem zur konstruktion von homologen rekombinationsvektoren
SI1651769T1 (sl) Uporaba konstruktov, ki obsegajo rekombinacijske sekvenčne motive za povečanje genske ekspresije v mahu
WO2002063039A3 (en) Gene silencing gene
HUP0002320A2 (hu) Eljárás gének helyspecifikus integrálására emlős sejtekbe homológ rekombinációval és az eljárás végrehajtására alkalmas vektorok